0002000790-23-000001.txt : 20231120 0002000790-23-000001.hdr.sgml : 20231120 20231120131815 ACCESSION NUMBER: 0002000790-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231120 DATE AS OF CHANGE: 20231120 EFFECTIVENESS DATE: 20231120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Centese, Inc. CENTRAL INDEX KEY: 0002000790 IRS NUMBER: 813152042 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-497696 FILM NUMBER: 231422090 BUSINESS ADDRESS: STREET 1: 4156 S 52ND ST CITY: OMAHA STATE: NE ZIP: 68117 BUSINESS PHONE: 888-220-0040 MAIL ADDRESS: STREET 1: 4156 S 52ND ST CITY: OMAHA STATE: NE ZIP: 68117 D 1 primary_doc.xml X0708 D LIVE 0002000790 Centese, Inc. 4156 S 52ND ST OMAHA NE NEBRASKA 68117 888-220-0040 DELAWARE Esculon, Inc. None Corporation true Evan Luxon c/o Centese, Inc. 4156 S 52nd St Omaha NE NEBRASKA 68117 Executive Officer Director Dan Burnett c/o Centese, Inc. 4156 S 52nd St Omaha NE NEBRASKA 68117 Director Alan Chesler c/o Centese, Inc. 4156 S 52nd St Omaha NE NEBRASKA 68117 Director Deepak Gangahar c/o Centese, Inc. 4156 S 52nd St Omaha NE NEBRASKA 68117 Director Radu Cautis c/o Centese, Inc. 4156 S 52nd St Omaha NE NEBRASKA 68117 Director Other Health Care Decline to Disclose 06b false 2023-11-03 false true true true false 1 23101545 15101545 8000000 Of the $8,000,000.06 Total Remaining to be Sold, $5,746,280.94 of this has been issued in Series B-1 Preferred Stock Warrants. The correct Total Remaining to be Sold amount is $2,253,719.12. false 50 0 0 0 false Centese, Inc. /s/ Evan Luxon Evan Luxon President and Chief Executive Officer 2023-11-20